Safety and quality assessment of 175 illegal sexual enhancement products seized in red-light districts in Singapore

Drug Safety

Volumn 32, Issue 12, 2009, Pages 1141-1146

  Low, Min Yong ^a,b   Zeng, Yun ^a   Li, Lin ^b   Ge, Xiao Wei ^a   Lee, Ruth ^a   Bloodworth, Bosco Chen ^a   Koh, Hwee Ling ^b  

^a HEALTH SCIENCES AUTHORITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CHLORAMPHENICOL; GLIBENCLAMIDE; ILLICIT DRUG; LIDOCAINE; METHANOL; NAPROXEN; PHOSPHODIESTERASE V INHIBITOR; SIBUTRAMINE; SILDENAFIL; TADALAFIL; VARDENAFIL;

ARTICLE; AUTHORITY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG LABELING; DRUG QUALITY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FLUSHING; HEADACHE; HEALTH SCIENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOGLYCEMIA; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; SEXUAL BEHAVIOR; SEXUAL HEALTH; SIDE EFFECT; SINGAPORE; VISUAL DISORDER;

DRUG CONTAMINATION; DRUG TOXICITY; ERECTILE DYSFUNCTION; GLYBURIDE; HUMANS; LEGISLATION, DRUG; MALE; PIPERAZINES; PURINES; RISK ASSESSMENT; SINGAPORE; SULFONES;

EID: 70449699709     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11316690-000000000-00000     Document Type: Article

References (28)

1. Selvin E, Burnett AL, Plato EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007; 120 (2): 151-157
2. Sobel RE, Reynolds RF. Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular events. Curr Med Res Opin 2008; 24 (7): 1861-1868
3. Kontaras K, Varnavas V, Kyriakides ZS. Does sildenafil cause myocardial infarction or sudden cardiac death? Am J Cardiovasc Drugs 2008; 8 (1): 1-7
4. Habek M, Petravic D. Stroke: an adverse reaction to silde-nafil. Clin Neuropharmacol 2006; 29 (3): 165-167
5. Milman HA, Amold SB. Neurologic, psychological and aggressive disturbances with sildenafil. Ann Pharmacother 2002; 36 (7-8): 1129-1134
6. Lloyd MJ, Fraunfelder FW. Drug-induced optic neuro-pathies. Drugs Today 2007; 43 (11): 827-836
7. Wooltorton E. Visual loss with erectile dysfunction medi-cations. Can Med Assoc J 2006 Aug; 175 (4): 355
8. Laties AM. Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date. Drug Saf 2009; 32 (1): 1-18
9. Nencini C, Barberi L, Runci FM, et al. Retinopathy induced by drugs and herbal medicines. Eur Rev Med Pharmacol Sci 2008; 12 (5): 293-298
10. Gorkin L, Hvidsten K, Sobel RE, et al. Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract 2006; 60 (4): 500-503
11. Laties A, Sharlip I. Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med 2006; 3 (1): 12-27
12. Philip A, Ramchandani S, Dorrance K, et al. Sildenafil-induced thrombocytopenia. Ann Intern Med 2008; 149 (6): 437-449
13. Blok-Tip L, Zomer B, Bakker F, et al. Structural elucidation of sildenafil analogues in herbal products. Food Addit Contam 2004; 21: 737-748
14. Bogusz MJ, Huda H, Al-Enazi E, et al. Application of LC-ESI-MS-MS for detection of synthetic adulterants in herbal remedies. J Pharm Biomed Anal 2006; 41 (2): 554-564
15. Lam YH, Poon WT, Lai CK, et al. Identification of a novel vardenafil analogue in herbal product. J Pharm Biomed Anal 2007; 46 (4): 804-807
16. Oh SS, Zou P, Low MY, et al. Detection of sildenafil ana-logues in herbal products for erectile dysfunction. J Toxicol Environ Health A 2006; 69: 1951-1958
17. Shin MH, Hong MK, Kim WS, et al. Identification of a new analogue of sildenafil added illegally to a functional food for penile erectile dysfunction. Food Addit Contam 2003; 20: 793-796
18. Zou P, Hou PL, Low MY, et al. Structural elucidation of a tadalafil analogue found as an adulterant of a herbal product. Food Addit Contam 2006; 23 (5): 446-451
19. Reepmeyer JC, Woodruff JT. Use of liquid chromato-graphy-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a ''natural'' herbal dietary supplement. J Chromatogr A 2006; 1125 (1): 67-75
20. Zou P, Hou P, Oh SS, et al. Isolation and identification of thiohomosildenafil and thiosildenafil in health supplements. J Pharm Biomed Anal 2008; 47 (2): 279-284
21. Hasegawa T, Takahashi K, Saijo M, et al. Isolation and structural elucidation of cyclopentynafil and N-octylnorta dalafil found in a dietary supplement. Chem Pharm Bull (Tokyo) 2009; 57 (2): 185-189
22. Health Sciences Authority of Singapore (HSA). HSA alerts on wider spread of harmful illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/etc/ medialib/hsa-library/corporate/pr20072009. Par.50960.File.tmp/PressRelease-HSAAlertsOnWiderSpreadOfHarmful IllegalHealthProducts-11Apr2008.pdf [Accessed 2008 May 20]
23. Health Sciences Authority of Singapore (HSA). HSA up-dates on serious adverse reaction cases associated with harmful illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/hsaportal/en/news-events/ press-releases/2008.-hsaArticleBody-45903-Down loadFile.tmp/HSAPressRelease- HSAUpdatesOnSerious AdverseReactionCasesAssociatedWithHarmfulIllegal HealthProducts-25Apr2008.pdf [Accessed, 2008 May 20]
24. Health Sciences Authority of Singapore (HSA). HSA up-dates on fatalities & serious adverse reactions associated with the use of illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/etc/ medialib/hsa-library/corporate/pr20072009.Par.62900.File.tmp/ MediaRelease-HSAUpdatesOnFatalities&ADRAssociated WithTheUseOfHarmfulIllegalHealthPdts-16May2008.pdf [Accessed 2008 May 20]
25. Health Sciences Authority of Singapore (HSA). HSA up-dates on fatalities & serious adverse reactions associated with the use of illegal health products [online]. Available from URL: http://www.hsa.gov.sg/publish/etc/ medialib/hsa-library/corporate/pr20072009.Par.16203.File.tmp/HSA PressRelease-HSAReiteratesConsumerAdvisoryMessages InSpiteDecreaseInSeriousAdverseReactionCasesAsssociated WithIllegalAphrodisiacProducts-31Oct2008.pdf [Accessed, 2008 Nov 10]
26. Kao SL, Chan CL, Tan B, et al. An unusual outbreak of hypoglycemia. N Engl J Med 2009; 360 (7): 734-736
27. Liu SY, Woo SO, Koh HL. HPLC and GC-MS screening of Chinese proprietary medicine for undeclared therapeutic substances. J Pharm Biomed Anal 2001; 24 (5-6): 983-992
28. Sweetman SC, editor. Martindale: the complete drug reference. 35th ed. London: Pharmaceutical Press, 2007